Sustained‐Release Terbutaline in Nocturnal Asthma
- 1 May 1986
- Vol. 41 (4) , 308-310
- https://doi.org/10.1111/j.1398-9995.1986.tb02034.x
Abstract
Fifteen adult patients with nocturnal asthma entered a double blind study. They received a single evening dose of one sustained-release (SR) terbutaline tablet a 7.5 mg or an identical placebo tablet for 1 week, each in a randomised cross-over fashion in addition to their usual medication. In the 12 evaluated patients there was no change in evening PEF but a significant improvement in morning PEF (P < 0.05) and in overnight fall of PEF (P < 0.01) on active treatment. Symptoms were improved by both placebo and active medication. Three patients experienced tremor as a side effect. A single evening dose of SR-terbutaline can be of help in nocturnal asthma.Keywords
This publication has 4 references indexed in Scilit:
- Effect of oral slow-release terbutaline on early morning dyspnoeaEuropean Journal of Clinical Pharmacology, 1985
- A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthmaRespiratory Medicine, 1982
- Terbutaline Depot Tablets in Asthma.Allergy, 1981
- Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.Thorax, 1980